Concerns over potential large-scale sell-off (overhang) of T&R Biofab are growing. The conversion price of the first tranche of convertible bonds (CB) has dropped to the minimum limit, and the ...

Inventage Lab, the parent company of KOSDAQ-listed Quratis, which must worry about maintaining its listing eligibility due to prolonged capital erosion, has stepped in with side support. Inventage Lab ...

As the stock market declines due to the impact of U.S. tariff policy, the conversion prices of the convertible bonds (CB) issued by listed companies continue to fall. When conversion prices drop, the ...